Have Insiders Sold Outset Medical Shares Recently?

Outset Medical

Outset Medical

OM

0.00

We note that the Outset Medical, Inc. (NASDAQ:OM) CFO, Principal Financial Officer & Principal Accounting Officer, Renee Gaeta, recently sold US$87k worth of stock for US$4.94 per share. It might not be a huge sale, but it did reduce their holding size 13%, hardly encouraging.

The Last 12 Months Of Insider Transactions At Outset Medical

In fact, the recent sale by Renee Gaeta was the biggest sale of Outset Medical shares made by an insider individual in the last twelve months, according to our records. That means that an insider was selling shares at around the current price of US$4.58. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).

Outset Medical insiders didn't buy any shares over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
NasdaqGS:OM Insider Trading Volume June 8th 2026

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

Does Outset Medical Boast High Insider Ownership?

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. Our data suggests Outset Medical insiders own 2.8% of the company, worth about US$2.4m. I generally like to see higher levels of ownership.

What Might The Insider Transactions At Outset Medical Tell Us?

Insiders sold Outset Medical shares recently, but they didn't buy any. And even if we look at the last year, we didn't see any purchases. Insiders own relatively few shares in the company, and when you consider the sales, we're not particularly excited about the stock. So we'd only buy after very careful consideration. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Outset Medical.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.